Innovent Biologics (HKG:1801) granted 55,900 share options to five grantees and 488,200 restricted shares to 23 grantees under employees incentive scheme according to a Thursday filing with the Hong Kong Exchange.
The exercise price of the options is HK$38.38 per share and the exercise period of the options will not be longer than 10 years from the date of the grant.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。